WiseGuyReports have announced the addition of a new report titled “Cell Therapy Processing: Global Markets and Technologies”.
Summary
There are numerous indications that can be cured using cell therapies, and with increased R&D activities for cell therapies, the number of therapeutic uses is anticipated to increase in the near future. Some of the indications under investigation for the treatment using cell therapy are cerebral disorders such as Parkinson’s disease and Alzheimer’s disease, and also cardiovascular disease. Cardiovascular disease could be treated using cell therapies with the aim to restore normal heart functions. Moreover, many studies are undergoing in the attempt to improve the safety and efficacy in treatment of different malignancies. Cell therapy could also be used to cure metabolic disorder such as diabetes mellitus type 1 where there is lack of insulin production in the patient. Researchers are also trying to restore normal liver and kidney function by introducing modified cells of respective origins. Presently, cell therapy could be a promising technique for the treatment of numerous conditions such as orthopedic, oncology, neurological and variety of autoimmune diseases. The increase in the potential of cell therapies in the treatment of diseases associated with lungs using stem cell therapies is anticipated to drive the market’s growth in the near future. In addition, improved understanding of the role of stem cells in inducing development of functional lung cells from both embryonic stem cells (ESCs) and induced pluripotent stem (iPS) cells offers lucrative opportunities for the cell therapy processing market’s growth. The rising significance of stem cell therapies provides further understanding of lung biology and repair after lung injury, and further a sound scientific basis for therapeutic use of cell therapies and bioengineering approaches in the treatment of lung diseases.
Increase in the incidence of cardiovascular diseases, rise in the demand for chimeric antigen receptor (CAR) T cell therapy, and increase in the development of stem cell therapy approaches are expected to drive the market’s growth. However, bottlenecks experienced by manufacturers during commercialization of cell therapies and high costs associated with cell therapies are restraining the market’s growth. In addition, the rise in the development of allogeneic cell therapy is expected to offer lucrative opportunities for the market’s growth. Allogeneic cell therapy involves chemoradio therapeutic conditioning therapy that is followed by transplantation of hematopoietic stem cells as well as lymphocytes isolated from allogeneic healthy donors for treatment of various chronic diseases. Allogeneic means from “one person to another,” whereas the converse is autologous, meaning from “one person back to the same person after processing.”
Hematopoietic stem cell transplantation is used for treatment of a variety of blood cancers and hematologic conditions. This transplantation is the most frequently used cell therapy procedure. The cell therapy processing market is classified based on offering type, application and region. The market by application is classified into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair and others based on the applications of cell therapy. Whereas, based on offering type, the market is classified into products, services, and software.
Request Sample Report at https://www.wiseguyreports.com/sample-request/3096321-cell-therapy-processing-global-markets-and-technologies
Report Scope:
This research report presents an in-depth analysis of the global cell therapy processing market by offering type, application and geographic regional markets. The report includes key inhibitors that affect various factors that help in growth of cell therapy processing. The report discusses the role of supply chain members from manufacturers to researchers. The report analyzes key companies operating in the global cell therapy processing market. In-depth patent analysis in the report will provide extensive technological trends across years and regions such as North America, Europe, Asia-Pacific and ROW.
The cell therapy processing market is mainly segmented into three major components: offering type, application and region. Based on offering type, the market is segmented into products (cell lines, instruments, among others), services (product design, process design, among others) and software (enabling software). Based on application, the market is categorized into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair, cancer and others. The market is segmented by region into North America, Europe, Asia-Pacific and the ROW.
The cell therapy processing market is mainly segmented into three major components: offering type, application and region. Based on offering type, the market is segmented into products (cell lines, instruments, among others), services (product design, process design, among others) and software (enabling software). Based on application, the market is categorized into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair, cancer and others. The market is segmented by region into North America, Europe, Asia-Pacific and the ROW.
Report Includes:
– 40 data tables and 25 additional tables
– An overview of the global market for cell therapy processing technologies
– Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
– Analysis of the market by technology, application, and region
– An outline of the present state of applications of rainwater harvesting
– Descriptions of trends in price and price-performance and other factors, including demand in the market
– Profiles of key companies in the market, including Biotime Inc., Cell Design Labs., Flodesign Sonics, Lonza Group Ltd. and Sanbio Co. Ltd.
Companies Mentioned:
BIOTIME INC.
Bone Therapeutics Sa
CALADRIUS BIOSCIENCES
CELL DESIGN LABS
Cell Therapies Pty Ltd
Cellbiomed Group
Flodesign Sonics
Iovance Biotherapeutics Inc.
LONZA GROUP LTD.
MERCK KGAA
Nantworks Llc
Neurogeneration Inc.
NOVARTIS
PLASTICELL LTD.
Regen Biopharma Inc.
Regeneus Ltd.
Sanbio Co. Ltd.
SARTORIUS STEDIM BIOTECH
Stemgenex Medical Group
Targazyme Inc.
View Detailed Report at https://www.wiseguyreports.com/reports/3096321-cell-therapy-processing-global-markets-and-technologies
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Breakdown by Offering Type
Chapter 5 Market Breakdown by Application
Chapter 6 Market Breakdown by Region
Chapter 7 Government Regulations
Chapter 8 Patent Review
Chapter 9 Analysis of Market Opportunities
Chapter 10 Company Profiles
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
